Evaluation of Safety of a Newly Formulated Pirfenidone in Chronic Kidney Disease: A Non-Randomized P...
Evaluation of Safety of a Newly Formulated Pirfenidone in Chronic Kidney Disease: A Non-Randomized Pilot Study in Mexican Patients
About this item
Full title
Author / Creator
Publisher
Brisbane: Codon Publications
Journal title
Language
English
Formats
Publication information
Publisher
Brisbane: Codon Publications
Subjects
More information
Scope and Contents
Contents
The aim of this pilot clinical trial was to evaluate the safety of a new formulation of prolonged-release Pirfenidone (PR-PFD) in chronic kidney disease (CKD), specifically focal and segmental glomerular hyalinization (FSGH). Open-label, pilot, nonrandomized trial. Eighteen patients previously diagnosed with CKD stages 1– 5 according to “Kidney Dis...
Alternative Titles
Full title
Evaluation of Safety of a Newly Formulated Pirfenidone in Chronic Kidney Disease: A Non-Randomized Pilot Study in Mexican Patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_2af6ef8cbf7f48da87aa78b37d0f2786
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2af6ef8cbf7f48da87aa78b37d0f2786
Other Identifiers
ISSN
2207-3744
E-ISSN
2207-3744
DOI
10.15586/jrenhep.2020.61
